6.
Joaquim A, Gionbelli M, Gosmann G, Fuentefria A, Lopes M, de Andrade S
. Novel Antimicrobial 8-Hydroxyquinoline-Based Agents: Current Development, Structure-Activity Relationships, and Perspectives. J Med Chem. 2021; 64(22):16349-16379.
DOI: 10.1021/acs.jmedchem.1c01318.
View
7.
Rbaa M, Jabli S, Lakhrissi Y, Ouhssine M, Almalki F, Hadda T
. Synthesis, antibacterial properties and bioinformatics computational analyses of novel 8-hydroxyquinoline derivatives. Heliyon. 2019; 5(10):e02689.
PMC: 6820249.
DOI: 10.1016/j.heliyon.2019.e02689.
View
8.
Domalaon R, Idowu T, Zhanel G, Schweizer F
. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?. Clin Microbiol Rev. 2018; 31(2).
PMC: 5967690.
DOI: 10.1128/CMR.00077-17.
View
9.
Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V
. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Drug Des Devel Ther. 2013; 7:1157-78.
PMC: 3793592.
DOI: 10.2147/DDDT.S49763.
View
10.
Trotsko N
. Antitubercular properties of thiazolidin-4-ones - A review. Eur J Med Chem. 2021; 215:113266.
DOI: 10.1016/j.ejmech.2021.113266.
View
11.
Salam M, Al-Amin M, Salam M, Pawar J, Akhter N, Rabaan A
. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare (Basel). 2023; 11(13).
PMC: 10340576.
DOI: 10.3390/healthcare11131946.
View
12.
. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024; 404(10459):1199-1226.
PMC: 11718157.
DOI: 10.1016/S0140-6736(24)01867-1.
View
13.
Cascioferro S, Parrino B, Carbone D, Schillaci D, Giovannetti E, Cirrincione G
. Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance. J Med Chem. 2020; 63(15):7923-7956.
PMC: 7997583.
DOI: 10.1021/acs.jmedchem.9b01245.
View
14.
Nerella S, Alvala R, Kalle A, Alvala M
. Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors. Future Med Chem. 2024; 16(9):843-857.
PMC: 11188815.
DOI: 10.4155/fmc-2023-0273.
View
15.
Bhat S, Jagruthi P, Srinivas A, Arifuddin M, Qureshi I
. Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1. Eur J Med Chem. 2019; 186:111860.
DOI: 10.1016/j.ejmech.2019.111860.
View
16.
Zhu M, Tse M, Weller J, Chen J, Blainey P
. The future of antibiotics begins with discovering new combinations. Ann N Y Acad Sci. 2021; 1496(1):82-96.
PMC: 8290516.
DOI: 10.1111/nyas.14649.
View
17.
Singh P, Goud N, Swain B, Sahoo S, Choli A, Angeli A
. Synthesis of a new series of quinoline/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors. Bioorg Med Chem Lett. 2022; 70:128809.
DOI: 10.1016/j.bmcl.2022.128809.
View
18.
Prestinaci F, Pezzotti P, Pantosti A
. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015; 109(7):309-18.
PMC: 4768623.
DOI: 10.1179/2047773215Y.0000000030.
View
19.
Kaur Manjal S, Kaur R, Bhatia R, Kumar K, Singh V, Shankar R
. Synthetic and medicinal perspective of thiazolidinones: A review. Bioorg Chem. 2017; 75:406-423.
DOI: 10.1016/j.bioorg.2017.10.014.
View
20.
Rossi R, Ciofalo M
. An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety. Molecules. 2020; 25(21).
PMC: 7663458.
DOI: 10.3390/molecules25215133.
View